1. Home
  2. CRVS vs CAN Comparison

CRVS vs CAN Comparison

Compare CRVS & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • CAN
  • Stock Information
  • Founded
  • CRVS 2014
  • CAN 2013
  • Country
  • CRVS United States
  • CAN Singapore
  • Employees
  • CRVS N/A
  • CAN N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • CAN Semiconductors
  • Sector
  • CRVS Health Care
  • CAN Technology
  • Exchange
  • CRVS Nasdaq
  • CAN Nasdaq
  • Market Cap
  • CRVS 305.4M
  • CAN 384.3M
  • IPO Year
  • CRVS 2016
  • CAN 2019
  • Fundamental
  • Price
  • CRVS $3.95
  • CAN $0.71
  • Analyst Decision
  • CRVS Strong Buy
  • CAN Strong Buy
  • Analyst Count
  • CRVS 4
  • CAN 6
  • Target Price
  • CRVS $15.00
  • CAN $2.67
  • AVG Volume (30 Days)
  • CRVS 1.2M
  • CAN 28.9M
  • Earning Date
  • CRVS 08-05-2025
  • CAN 08-14-2025
  • Dividend Yield
  • CRVS N/A
  • CAN N/A
  • EPS Growth
  • CRVS N/A
  • CAN N/A
  • EPS
  • CRVS N/A
  • CAN N/A
  • Revenue
  • CRVS N/A
  • CAN $317,009,000.00
  • Revenue This Year
  • CRVS N/A
  • CAN $160.28
  • Revenue Next Year
  • CRVS N/A
  • CAN $35.68
  • P/E Ratio
  • CRVS N/A
  • CAN N/A
  • Revenue Growth
  • CRVS N/A
  • CAN 65.68
  • 52 Week Low
  • CRVS $1.75
  • CAN $0.53
  • 52 Week High
  • CRVS $10.00
  • CAN $3.27
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 50.43
  • CAN 53.84
  • Support Level
  • CRVS $3.55
  • CAN $0.58
  • Resistance Level
  • CRVS $4.09
  • CAN $0.62
  • Average True Range (ATR)
  • CRVS 0.31
  • CAN 0.05
  • MACD
  • CRVS -0.03
  • CAN 0.01
  • Stochastic Oscillator
  • CRVS 49.14
  • CAN 75.53

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

Share on Social Networks: